Benitec Biopharma
-$0.02 (-0.82%) Today
-$0.03 (-1.24%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNTC and other ETFs, options, and stocks.
About BNTC
Benitec Biopharma, Inc. is a development-stage biotechnology company, which focuses on the advancement of novel genetic medicines. The firms proprietary platforms includes DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration.
CEO
Jerel A. Banks
Employees
14
Headquarters
Hayward, California
Founded
2019
BNTC Key Statistics
Market cap
19.78M
Price-Earnings ratio
—
Dividend yield
—
Average volume
37.97K
High today
$2.48
Low today
$2.33
Open price
$2.42
Volume
16.73K
52 Week high
$10.49
52 Week low
$2.28
BNTC Earnings
-$2.45
-$1.63
-$0.82
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Feb 8, Pre-Market